Literature DB >> 14607663

Effect of morphine and M-cholinoceptor blocking drugs on human sphincter of Oddi during choledochofiberscopy manometry.

Shuo-Dong Wu1, Jing Kong, Wei Wang, Qiang Zhang, Jun-Zhe Jin.   

Abstract

OBJECTIVE: To evaluate the effects of morphine on the human sphincter of Oddi pressure and the antagonism of anticholinergic agents against morphine.
METHODS: The action of these drugs on the sphincter of Oddi (SO) was evaluated by means of choledochofiberscopy manometry in 40 operated patients with T-tube. The patients were divided randomly into 4 groups: anisodamine, atropine, buscopan, and control. The following data were recorded: duodenal pressure (DP), basal pressure of the sphincter of Oddi (BPSO), contractive amplitude of the sphincter of Oddi (CASO), contractive frequency of the sphincter of Oddi (CFSO), contractive duration of the sphincter of Oddi (CDSO), and pressure of the common bile duct (PCBD). Both morphine and anticholinergic agents were given intramuscularly.
RESULTS: After injection of 10 mg morphine, BPSO, CASO, CFSO, and PCBD increased significantly. After injection of 15 mg anisodamine or 0.75 mg atropine, CASO, BPSO declined obviously, and after injection of 20 mg buscopan, CASO, BPSO, CFSO declined obviously, but in anisodamine, atropine and buscopan groups, they differed insignificantly.
CONCLUSIONS: The results illustrate that SO manometry via choledochofiberscopy is a new method for SO dynamic study. Morphine can increase DP, BPSO, CASO, PCBD, but anisodamine atropine and buscopan can antagonize the effect of morphine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607663

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  7 in total

1.  Nitroester drug's effects and their antagonistic effects against morphine on human sphincter of Oddi motility.

Authors:  Shuo-Dong Wu; Zhen-Hai Zhang; Dong-Yan Li; Jun-Zhe Jin; Jing Kong; Zhong Tian; Wei Wang; Min-Fei Wang
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

2.  Anisodamine accelerates spontaneous passage of single symptomatic bile duct stones ≤ 10 mm.

Authors:  Jun Gao; Xue-Mei Ding; Shan Ke; Yi-Ming Zhou; Xiao-Jun Qian; Rui-Liang Ma; Chun-Min Ning; Zong-Hai Xin; Wen-Bing Sun
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

3.  Choledochoscope manometry about different drugs on the Sphincter of Oddi.

Authors:  Jing Kong; Shuo-Dong Wu; Xiao-Bo Zhang; Zhen-Sheng Li; Gang Shi; Wei Wang; Jun-Zhi Chen
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 4.  The sphincter of oddi.

Authors:  Antonio Bosch; Luis R Peña
Journal:  Dig Dis Sci       Date:  2007-03-14       Impact factor: 3.487

5.  Merit of anisodamine combined with opioid δ-receptor activation in the protection against myocardial injury during cardiopulmonary bypass.

Authors:  Xuan Hong; Huimin Fan; Rong Lu; Paul Chan; Zhongmin Liu
Journal:  Biomed Res Int       Date:  2013-12-10       Impact factor: 3.411

6.  Chronic extrahepatic bile duct dilatation: sonographic screening in the patients with opioid addiction.

Authors:  H Farahmand; M PourGholami; M Sheikh Fathollah
Journal:  Korean J Radiol       Date:  2007 May-Jun       Impact factor: 3.500

Review 7.  Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature.

Authors:  Enrico M Zardi; Francesco Di Matteo; Daniele Santini; Valentina Uwechie; Pierfilippo Crucitti; Massimiliano Carassiti; Antonio Picardi; Eleonora Perrella; Marco Caricato; Giuseppe Tonini; Roberto Coppola; Antonella Afeltra
Journal:  J Exp Clin Cancer Res       Date:  2008-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.